Analysts expect Royalty Pharma plc to report revenue of 849.02 M for Q3 26, against a range of 799.12 M to 898.92 M. The most recent reported quarter, Q2 26, came in at 773.00 M, a 4.1% beat against the 742.65 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 735.00 M | 742.00 M | 839.00 M | 727.00 M | 814.00 M | 874.00 M | 925.00 M | 773.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 761.86 M | 714.66 M | 716.78 M | 779.50 M | 701.62 M | 868.06 M | 966.63 M | 780.04 M | 898.92 M | 1.06 B | 969.52 M | 874.24 M | 1.02 B | 1.10 B | 1.18 B | 1.01 B | ||||||||||
| Low Estimate | 682.10 M | 596.05 M | 625.84 M | 644.77 M | 659.01 M | 811.19 M | 885.89 M | 705.25 M | 799.12 M | 891.82 M | 796.01 M | 716.67 M | 932.65 M | 1.01 B | 975.27 M | 841.39 M | ||||||||||
| Consensus Estimate | 721.98 M | 655.35 M | 671.31 M | 712.13 M | 680.32 M | 839.63 M | 926.26 M | 742.65 M | 849.02 M | 974.32 M | 882.76 M | 795.46 M | 978.59 M | 1.06 B | 1.08 B | 924.35 M |
Analysts expect Royalty Pharma plc to report earnings per share of 1.20 for Q3 26, against a range of 1.09 to 1.31. The most recent reported quarter, Q2 26, came in at 1.32, a 10.9% beat against the 1.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.92 | 1.15 | 0.75 | 1.14 | 1.17 | 1.47 | 1.30 | 1.32 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.98 | 1.15 | 1.04 | 1.12 | 1.11 | 1.34 | 1.23 | 1.27 | 1.31 | 1.65 | 1.10 | 1.09 | 1.28 | 1.65 | 1.59 | 1.48 | ||||||||||
| Low Estimate | 0.80 | 1.01 | 0.92 | 0.98 | 0.97 | 1.16 | 1.05 | 1.11 | 1.09 | 1.53 | 0.92 | 0.95 | 1.12 | 1.41 | 1.37 | 1.24 | ||||||||||
| Consensus Estimate | 0.89 | 1.08 | 0.98 | 1.05 | 1.04 | 1.25 | 1.14 | 1.19 | 1.20 | 1.59 | 1.01 | 1.02 | 1.20 | 1.53 | 1.48 | 1.36 |
Pull Wall Street consensus for Royalty Pharma plc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RPRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RPRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RPRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();